World's Best Scientists 2026 revealed!
Qiang Pan-Hammarström

Qiang Pan-Hammarström

D-Index & Metrics

Immunology

D-Index
72
Citations
19831
World Ranking
2207
National Ranking
41

Qiang Pan-Hammarström publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Qiang Pan-Hammarström sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 238 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Qiang Pan-Hammarström D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Qiang Pan-Hammarström sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Qiang Pan-Hammarström is affiliated with the Karolinska Institute in Sweden and has an extensive research output primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work encompasses a range of subfields including Infectious Diseases, Immunology, Molecular Biology, Genetics, and Epidemiology.

The main topics that define their research contributions are as follows:

  • SARS-CoV-2 and COVID-19 Research
  • Immunodeficiency and Autoimmune Disorders
  • COVID-19 Clinical Research Studies
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Monoclonal and Polyclonal Antibodies Research
  • Chronic Lymphocytic Leukemia Research

The scientist has published multiple papers in notable venues, with frequent appearances in bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, The Journal of Experimental Medicine, Science Immunology, and the Journal of Allergy and Clinical Immunology.

Some recent papers include:

  • "Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths" (2021, Science Immunology)
  • "X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19" (2021, Science Immunology)
  • "Genomic basis for RNA alterations in cancer" (2020, Nature)
  • "Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection" (2021, Med)
  • "SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways" (2020, Cancer Cell)

Their frequent co-authors reflect collaboration with other researchers, including Lennart Hammarström, Likun Du, Hassan Abolhassani, Harold Marcotte, and Jean-Laurent Casanova.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

    U Salzer;H M Chapel;A D B Webster;Q Pan-Hammarström

  • Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity

    Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans

    Klaus Warnatz;Ulrich Salzer;Marta Rizzi;Beate Fischer

  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

    Takaki Asano;Bertrand Boisson;Bertrand Boisson;Bertrand Boisson;Fanny Onodi;Daniela Matuozzo;Daniela Matuozzo

  • Genomic basis for RNA alterations in cancer

    Claudia Calabrese;Natalie R. Davidson;Deniz Demircioğlu;Deniz Demircioğlu;Nuno A. Fonseca

  • Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.

    Qiang Pan-Hammarström;Ulrich Salzer;Likun Du;Jan Fredrik Björkander

  • B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity.

    Jason Qian;Qiao Wang;Marei Dose;Nathanael Pruett

  • Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

    Ulrich Salzer;Chiara Bacchelli;Sylvie Buckridge;Qiang Pan-Hammarström

  • Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR

    Stephan Borte;Ulrika von Döbeln;Anders Fasth;Ning Wang

  • Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

    John D. Rioux;John D. Rioux;Philippe Goyette;Philippe Goyette

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

    Unknown

  • Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas

    Ryan D. Morin;Sarit Assouline;Miguel Alcaide;Arezoo Mohajeri

  • Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

    Konstantinos Georgiou;Longyun Chen;Mattias Berglund;Weicheng Ren

  • Selective IgA deficiency in early life: association to infections and allergic diseases during childhood.

    Magdalena Janzi;Inger Kull;Ronald Sjöberg;Jinghong Wan

  • Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

    Unknown

  • Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency

    Ricardo C Ferreira;Qiang Pan-Hammarström;Robert R Graham;Vesela Gateva

  • Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

    Peter K. Gregersen;Roman Kosoy;Annette T. Lee;Janine Lamb

  • Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea

    Neha Pant;Anna Hultberg;Yaofeng Zhao;Lennart Svensson

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection.

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

  • Role for Msh5 in the regulation of Ig class switch recombination.

    Hideharu Sekine;Ricardo C. Ferreira;Qiang Pan-Hammarström;Robert R. Graham

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

  • Relevance of biallelic vs monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

    U S Salzer;C Bacchelli;S Buckridge;Q Pan-Hammar-Strom

Frequent Co-Authors

Lennart Hammarström
Lennart Hammarström Karolinska Institute
Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Nima Rezaei
Nima Rezaei Tehran University of Medical Sciences
Ulrich Salzer
Ulrich Salzer University of Freiburg
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Timothy W. Behrens
Timothy W. Behrens Xaira Therapeutics
Stuart G. Tangye
Stuart G. Tangye Garvan Institute of Medical Research
Richard Rosenquist
Richard Rosenquist Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which benefit from specialized nursing education. For nurses aiming to advance their career, the transition from a Family Nurse Practitioner to a more specialized role is common. Programs focused on fnp to acute care np provide the necessary skills for acute patient management, complementing immunology expertise.

For those looking to accelerate their nurse practitioner education, pursuing an accelerated fnp program online can be a time-efficient path. These programs combine rigorous coursework with clinical experience, preparing graduates to handle complex immunological conditions in clinical settings.

Non-nurses interested in healthcare and immunology can start with online nursing programs designed for beginners. High-quality online absn programs for non nurses make it possible to enter nursing with a focus on immunology topics, broadening career opportunities.

Choosing the right accelerated Bachelor of Science in Nursing program is critical. Programs with low barriers to entry are ideal for many students and can be found by exploring absn programs with high acceptance rates. This flexibility helps prospective immunology students transition smoothly into nursing careers that support their interests.

Best Scientists Citing Qiang Pan-Hammarström

Trending Scientists

Recently Published Articles